Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

07/01/03 Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.        

06/27/03 SURVEY FINDS 395 MEDICINES OFFER HOPE FOR CANCER VICTIMS        

06/27/03 No Cancer Link to Wires- Study: No evidence electromagnetic fields cause breast tumors        

06/24/03 Glioblastoma in kidney transplant recipients. Report of five cases.        

06/24/03 Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project.        

06/24/03 Wafer attacks tumors        

06/24/03 Psychometric- and quality-of-life assessment in long-term glioblastoma survivors.        

06/24/03 Ken Stover is riding his bike in the Tour of the California Alps to raise money for the Musella Foundation.        

06/22/03 Do you believe in miracles?        

06/20/03 Application of Diffusion Tensor Imaging to Magnetic-Resonance-Guided Brain Tumor Resection        

06/20/03 A risky operation offers family hope        

06/20/03 Reovirus Prolongs Survival and Reduces the Frequency of Spinal and Leptomeningeal Metastases from Medulloblastoma        

06/20/03 WORK OF CLEVELAND CLINIC RESEARCHERS MAY LEAD TO A BLOOD TEST FOR BRAIN TUMOR DIAGNOSIS        

06/16/03 RSR13 Plus Cranial Radiation Therapy in Patients With Brain Metastases: Comparison With the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.        

06/16/03 Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the Treatment of Recurrent and Progressive Malignant Glioma: A North American Brain Tumor Consortium Study.        

06/16/03 Michael T. Glass Glioblastoma Research Foundation will be hosting a fundraiser at DIP (416 3rd Avenue between 29th and 30th) from 6:30 p.m.-9:30 p.m.        

06/16/03 Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas.        

06/14/03 First line chemotherapy with temozolomide (TMZ) in recurrent or progressive oligodendroglioma        

06/14/03 Temozolomide in glioblastoma: 4 years' experience with monthly or fortnigthly schedule        

---

Displaying Stories 5641 to 5660 of 7668
Previous 20           Next 20